May 19 (Reuters) - Alzamend Neuro Inc ALZN.O:
ALZAMEND NEURO ENROLLS FIRST PATIENT IN ITS PHASE II CLINICAL TRIAL OF AL001 “LITHIUM IN BRAIN” STUDY TAKING PLACE AT MASSACHUSETTS GENERAL HOSPITAL
ALZAMEND NEURO INC - TOPLINE DATA FOR AL001 EXPECTED BY YEAR END